0001493152-22-018605.txt : 20220705 0001493152-22-018605.hdr.sgml : 20220705 20220705195508 ACCESSION NUMBER: 0001493152-22-018605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20220705 DATE AS OF CHANGE: 20220705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barr Jason Michael CENTRAL INDEX KEY: 0001645550 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 221067062 MAIL ADDRESS: STREET 1: 902 BROADWAY, 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0306 4 2022-07-01 0 0000868278 ProPhase Labs, Inc. PRPH 0001645550 Barr Jason Michael 711 STEWART AVENUE, SUITE 200 GARDEN CITY, NY 11530 1 0 0 0 Option (right to buy) 12.92 2022-07-01 4 A 0 40000 0 A 2029-07-01 Common Stock 40000 40000 D The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022. /s/ Jason Barr 2022-07-05